English
Home > Products > CAS:595-33-5

China CAS:595-33-5 Manufacturer

Our growth depends to the superior products ,great talents and repeatedly strengthened technology forces for CAS:595-33-5, Our firm quickly grew in size and reputation because of its absolute dedication to superior quality manufacturing, substantial price of solutions and fantastic customer services.
CAS:595-33-5, Our company insists on the principle of "Quality First, Sustainable Development", and takes "Honest Business, Mutual Benefits" as our developable goal. All members sincerely thank all old and new customers' support. We'll keep working hard and offering you the highest-quality goods and service.

Related Products

Hot Products

  • Finasteride

    Finasteride

    Finasteride has EP, USP, CP, IP, JP specifications. CEP available, FDA, PMDA and GMP approved.

    CAS:98319-26-7

  • Levonorgestrel

    Levonorgestrel

    Levonorgestrel has speficications of CP/EP/USP. DMF,GMP and CEP available.

    CAS:797-63-7

  • Testosterone

    Testosterone

    Testosterone has CP,EP and USP specifications. CEP, DMF, WC, FDA available..

    CAS:58-22-0

  • Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride has USP specification. DMF approved.

    CAS:175865-59-5

  • 21-acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione

    21-acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione

    21-Acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione is an intermediate in the synthesis of Budesonide (B689490) related derivatives.

    CAS:3044-42-6

  • Levonorgestrel Capsules

    Levonorgestrel Capsules

    Levonorgestrel Capsules Specifications：0.75mg*2
    Indications：Emergency Contraceptive
  • Related Blog
  • Reviews

  • 2022 API Exhibition Qingdao

    August 2022
    Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
    Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
    99% manufactures meets the requirements of GMP.
    Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

  • CPHI & PMEC China 2024 Ended Successfully

    From June 19 to 21, the 22nd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2024), organized by Informa Markets and China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products and co-organized by Shanghai Bohua International Exhibition Co., LTD., was held in Shanghai. Nearly 3,500 well-known exhibitors at home and abroad gathered in Shanghai New International Expo Center (Pudong), attracting more than 60,000 professional buyers from more than 150 countries and regions, and a total of more than 90,000 industry colleagues to participate in the event.

  • 2024 VIETNAM MEDI-PHARM EXPO

    VIETNAM MEDI-PHARM EXPO 2024 will be held at Saigon Exhibition & Convention Center – SECC from August 1 to 3, our booth number is I19.

  • Welcome to CPhI JAPAN 2025

    CPhI JAPAN 2025 will be held at East Halls 6, Tokyo Big Sight from April 09-11,2025, our booth number is 6C-20a.

  • CPhI South East Asia 2025-See you at booth N33

    CPhI South East Asia 2025 will be held at MITEC, Kuala Lumpur, Malaysia from 16 Jul to 18 Jul 2025, our booth number is N33.

  • How Can Intermediates Category Solutions Streamline Your Production Process

    As someone who has spent over two decades navigating the complexities of industrial production, I've seen firsthand how bottlenecks in the middle stages can derail entire operations. That’s why I was particularly impressed when I began working with solutions from the Intermediates Category. For any production manager, finding tools that seamlessly integrate and accelerate the core of your workflow is the ultimate goal. This is where the strategic approach from Humanwell truly shines, offering a refined path to efficiency that many of us have been searching for.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept